ENVX:NASDAQEnovix Corporation Analysis
Data as of 2026-09-09 - not real-time
$3.16
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Enovix Corporation trades at $3.16, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Across the trailing 30 sessions it lost 20.4%. Momentum indicators put RSI at 36.6 (approaching oversold) with MACD reading bullish. Recent trading has carved out support near $3.06 and resistance around $5.03.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 259.2% above today's level. Revenue is growing at 20.8%.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 105.9%, a beta of 3.76 and a maximum drawdown of 76.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Near-term and long-term part ways here — sell short-term against hold longer out, with 3/10 conviction on the long call.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 259.2% above today's level. Revenue is growing at 20.8%.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 105.9%, a beta of 3.76 and a maximum drawdown of 76.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Near-term and long-term part ways here — sell short-term against hold longer out, with 3/10 conviction on the long call.
Top Market Events
Enovix Corporation ENVX delivered earnings and revenue surprises of +7.Second Quarter Revenue of $9.0 Million, Up 21% Year-over-Year, at High End of Guidance; First Half 2026 Revenue of...Enovix Corporation ENVX might move higher on growing optimism about its earnings prospects, which is reflected by its...
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 6.12
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 6.12
- Analyst targets imply +259.2% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Analyst targets imply +259.2% versus the current price
- Negative return on equity of -81.3%
- Revenue growth of +20.8%
Key Metrics & Analysis
Financial Health
Revenue Growth20.80%
P/E Ratio-5.0
ROE-81.28%
ROA-17.55%
Debt/Equity255.54
P/B Ratio3.2
Op. Cash Flow$-107378000
Free Cash Flow$-69503624
Industry P/E27.9
Technical Analysis
TrendBearish
RSI36.6
Support$3.06
Resistance$5.03
MA 20$3.54
MA 50$4.25
MA 200$6.12
MACDBullish
VolumeDecreasing
Fear & Greed Index92.04
Valuation
Target Price$11.35
Upside/Downside259.18%
GradeFair
TypeGrowth
Risk Assessment
Beta3.76
Volatility105.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.